Two decades of FFAR4 biology: From nutrient sensing to therapeutic targeting

Free fatty acid receptor 4 (FFAR4; also known as GPR120) serves as a key lipid-sensing G-protein-coupled receptor that mediates the physiological actions of long-chain fatty acids, particularly omega-3 polyunsaturated fatty acids. Over the past two decades, studies of FFAR4 have revealed its pivotal role in metabolic regulation, inflammation resolution, and energy balance. This review integrates recent advances from structural biology, physiology, and translational research to provide an updated framework of FFAR4 biology. In particular, we highlight new cryo-electron microscopy-based insights into receptor activation and ligand recognition; the expanding roles of FFAR4 in non-metabolic systems, such as the central nervous system and kidney; and recent progress in the clinical development of selective FFAR4 agonists. By bridging molecular mechanisms with therapeutic translation, this review offers a comprehensive perspective on FFAR4's functions in health and disease.

Authors

Institutions

Publication Details

Journal
Cell Reports
Published
2025-11-01
DOI
https://doi.org/10.1016/j.celrep.2025.116586
Citations
1
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
1.29

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Two decades of FFAR4 biology: From nutrient sensing to therapeutic targeting

Dayoung Oh, Yulin Kong, Shenglong Zhu
1 citations
Cell Reports
Diabetes Treatment and Management
1.29
article

Two decades of FFAR4 biology: From nutrient sensing to therapeutic targeting

Dayoung Oh, Yulin Kong, Shenglong Zhu
article en
1 citations

Abstract

Free fatty acid receptor 4 (FFAR4; also known as GPR120) serves as a key lipid-sensing G-protein-coupled receptor that mediates the physiological actions of long-chain fatty acids, particularly omega-3 polyunsaturated fatty acids. Over the past two decades, studies of FFAR4 have revealed its pivotal role in metabolic regulation, inflammation resolution, and energy balance. This review integrates recent advances from structural biology, physiology, and translational research to provide an updated framework of FFAR4 biology. In particular, we highlight new cryo-electron microscopy-based insights into receptor activation and ligand recognition; the expanding roles of FFAR4 in non-metabolic systems, such as the central nervous system and kidney; and recent progress in the clinical development of selective FFAR4 agonists. By bridging molecular mechanisms with therapeutic translation, this review offers a comprehensive perspective on FFAR4's functions in health and disease.

Cell ReportsVol. 44(11)
Jiangnan University (CN), Southwestern Medical Center (US), The University of Texas Southwestern Medical Center (US)
National Natural Science Foundation of China, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
Openalex Percentile: Top 14%
Diabetes Treatment and Management
1.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.